07:27 AM EDT, 08/11/2025 (MT Newswires) -- Sionna Therapeutics ( SION ) reported a Q2 net loss Monday of $0.41 per diluted share, narrowing from its loss of $2.71 a year earlier.
Two analysts polled by FactSet expected a loss of $0.65 per share.
No revenue was reported for the quarter ended June 30.
The company reported cash, cash equivalents and marketable securities of $337.3 million. The company said it expects its current cash position to fund operations into 2028.